This biotech derivative play could nearly double, UBS says
UBS sees a rosy outlook ahead for CryoPort as the headwinds that the business and the stock have faced dissipate. The bank upgraded shares of...
Tag : biotech
This biotech stock is a buy thanks to its cancer treatment pipeline, Citi says
BioNTech’s promising cancer treatments pipeline could lead to strong gains ahead, according to Citi. The bank initiated the biotech stock with a buy rating. Its...
Trump’s Early Policy Moves Create New Headaches for This Biotech Heavyweight
Policy shifts are compounding an already challenging growth picture for Illumina. ADVERTISEMENT: Hai, sobat pencinta slots pernahkah denger semboyan “slot demo”? jika tidak, bersiaplah jatuh...
Leerink upgrades this downbeat biotech, says investors should buy the dip
The sell-off in Regeneron Pharmaceuticals presents an opportunity for investors to buy the stock on the cheap, according to Leerink Partners. Analyst David Risinger upgraded...
Buy this biotech stock that can rally more than 65%, Goldman says
Investors should snap up Vera Therapeutics after a recent retreat, Goldman Sachs suggested. Analyst Paul Choi initiated coverage of the biotechnology stock at a buy...
Little-known biotech stock is a buy that’s primed to double in price: Goldman
MoonLake Immunotherapeutics ‘ experimental treatment for a chronic skin condition could boost its shares to new heights, according to Goldman Sachs. The bank upgraded the...
One biotech stock is ‘oncology powerhouse’ with 40% upside, says Truist
BioNTech SE could evolve into an “oncology powerhouse” after emerging as a premier vaccine player during the Covid-19 pandemic, according to Truist Securities. The investment...
Nvidia at an inflection point, biotech stock primed for a big gain ahead
Investors are looking ahead to Nvidia CEO Jensen Huang speaking at the Consumer Electronics Show and what that could mean for the artificial intelligence trade....
Innovative biotech stocks have a good chance of breaking out in 2025
Trends may be shifting in favor of biotech stocks in 2025 after several years of poor performance, but it would still be wise to place...
How to play a potential biotech breakout in 2025 with options
The iShares Biotechnology ETF (IBB) tracks the performance of the Nasdaq Biotechnology Index, providing exposure to U.S.-listed biotechnology and pharmaceutical companies. It is one of...